Overview of HPV Testing & Pap Test Market

on
Cervical cancer is one of the most common cancers found among women, which is caused due to the infection of human papilloma virus (HPV). Thanks to the advancements in technology, there are now different treatments and screening methods available such as HPV testing and Pap test, which help in the early detection of the cancer. The traditional test for detecting cervical cancer has been Pap test; however, HPV testing is increasingly being used nowadays in comparison to Pap test. HPV tests help in finding HPV of high risks. Rising cases of cervical cancer has led to a huge demand for HPV testing, thereby boosting the growth of HPV testing and Pap test market, globally.

Driving Factors and Restraints
The global HPV testing and Pap test market is growing at a significant rate due to the following factors:
  1. ·         Increasing cases of cervical cancer
  2. ·         Growing aging population
  3. ·         Increased government initiatives and fundin
  4. ·         Rising awareness regarding cervical cancer screening programs


Moreover, introduction of HPV primary screening tests has opened an array of growth opportunities for this market. However, changing regulatory guidelines for cervical cancer screening and HPV vaccination are some of the factors that may hamper the growth of this market. In addition, uncertain reimbursement scenario poses a major challenge that may also impact the growth of this market.

Market Predictions

The worldwide HPV testing and Pap test market which was estimated to be valued at USD 3,287.4 Million in 2015 is poised to reach USD 4,523.1 Million by 2020, growing at a CAGR of 6.6% from 2015 to 2020. Geographically, North America was the dominant market in 2015, and it is also likely to grow at the highest CAGR during the forecast period. The high growth in this region can be attributed to the rising cases of cervical cancer, growing awareness of cervical cancer screening programs, and increased government support.

Based on test type, the Pap test segment accounted for the largest share in 2015; however, the HPV testing segment is expected to grow at the highest CAGR, owing to the shift towards the use of HPV testing from Pap test, increasing cases of cervical cancer, and rising awareness regarding HPV screening. Among application, the segment of cervical screening application accounted for the largest share of the Pap test market in 2015. Based on end-user, the laboratories segment held the largest market share in 2015. However, the hospitals segment is projected to grow at the highest CAGR over the coming years.

Abbott Laboratories (U.S.), Qiagen N.V. (The Netherlands), Hologic Inc. (U.S.), Roche Diagnostics (Switzerland), Quest Diagnostics (U.S.), and Becton, Dickinson and Company (U.S.) are the key players operating in the global market for HPV testing.

Request PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=214207371

Research Scope
The global market for HPV testing and Pap test has been studied and forecasted on the basis of following segmentation:

·         Test Type: HPV Testing, Follow-up HPV Testing, Co-testing, HPV Primary Testing, Pap Test
·         Application: Pap Test, Cervical Cancer Screening, Vaginal Cancer Screening
·         End-User: Laboratories, Hospitals, Physician’s Offices & Clinics
·         Geography: North America, Europe, Asia-Pacific, RoW

Summary

The major factor driving HPV testing & Pap test market is the increasing number of cases of cervical cancer across the globe.

Comments

Post a Comment